Annual report pursuant to Section 13 and 15(d)

SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details)

v3.24.1
SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details) - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Income Tax Disclosure [Abstract]    
Net operating loss carry-forward $ 3,605,912 $ 3,204,894
Accrued expenses
Stock based compensation 211,162 58,106
Section 174 R&D expenses 369,533 193,236
Charitable contribution 221 221
Net deferred tax assets 4,186,828 3,456,457
Valuation allowance (4,186,828) (3,456,457)
Total net deferred tax asset